Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.510
+0.040 (2.72%)
Apr 23, 2025, 4:00 PM EDT - Market closed

Annovis Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
296919211014252
Upgrade
Market Cap Growth
-63.84%-63.84%75.03%-23.01%174.06%-
Upgrade
Enterprise Value
1957186789543
Upgrade
Last Close Price
1.515.0318.7013.4317.587.54
Upgrade
PB Ratio
2.297.46-24.763.873.206.89
Upgrade
P/TBV Ratio
3.167.46-3.873.206.89
Upgrade
Quick Ratio
2.722.721.353.6930.3313.96
Upgrade
Current Ratio
3.593.592.394.6830.5414.04
Upgrade
Return on Equity (ROE)
-3159.09%-3159.09%-546.40%-69.57%-55.68%-180.82%
Upgrade
Return on Assets (ROA)
-138.26%-138.26%-121.77%-38.88%-33.58%-89.86%
Upgrade
Return on Capital (ROIC)
-2143.41%-2143.41%-273.63%-43.79%-34.92%-126.89%
Upgrade
Earnings Yield
-83.57%-35.43%-29.29%-23.10%-10.17%-10.51%
Upgrade
Buyback Yield / Dilution
-35.60%-35.60%-10.55%-7.03%-20.88%-2132.36%
Upgrade
Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q